NISA INVESTMENT ADVISORS, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 121 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2018. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$640,000
+45.8%
4,392
+18.6%
0.01%
+100.0%
Q1 2022$439,000
+23.3%
3,702
+38.1%
0.00%0.0%
Q4 2021$356,000
+23.6%
2,681
+29.5%
0.00%
+50.0%
Q3 2021$288,000
+43.3%
2,0700.0%0.00%
+100.0%
Q2 2021$201,000
+42.6%
2,0700.0%0.00%0.0%
Q1 2021$141,000
-20.3%
2,0700.0%0.00%0.0%
Q4 2020$177,000
+50.0%
2,070
+13.7%
0.00%0.0%
Q3 2020$118,000
+202.6%
1,820
+237.0%
0.00%
Q2 2020$39,000
+8.3%
540
-49.1%
0.00%
Q1 2020$36,000
-50.7%
1,060
-21.2%
0.00%
-100.0%
Q4 2019$73,000
+58.7%
1,345
+22.3%
0.00%
Q3 2019$46,000
+475.0%
1,100
+511.1%
0.00%
Q2 2019$8,000
-11.1%
1800.0%0.00%
Q1 2019$9,000
+28.6%
1800.0%0.00%
Q4 2018$7,0000.0%1800.0%0.00%
Q3 2018$7,0001800.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q3 2018
NameSharesValueWeighting ↓
RP Management, LLC 1,111,111$154,344,00072.03%
Knoll Capital Management, LLC 856,844$119,024,00059.36%
ORACLE INVESTMENT MANAGEMENT INC 2,124,055$295,053,00036.73%
ARS Investment Partners, LLC 466,668$64,825,0006.49%
KINGDON CAPITAL MANAGEMENT, L.L.C. 365,373$50,754,0006.18%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 176,400$24,490,0005.91%
SILVERARC CAPITAL MANAGEMENT, LLC 61,897$8,598,0004.86%
DAFNA Capital Management LLC 88,100$12,238,0003.25%
Avidity Partners Management LP 934,200$129,770,0002.88%
Eventide Asset Management 1,325,000$184,056,0002.43%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders